References
- 1. Acharya SS. Inherited Abnormalities of Fibrinogen [Internet]. Background, Pathophysiology, Epidemiology. Medscape; 2016. Available from: https://emedicine.medscape.com/article/960677-overview.
- 2. Altes P, Perez P, Esteban C, Muñoz-Torrero JFS, Aguilar E, García-Díaz AM, et al. Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease. Angiology. 2017 Jul: 000331971773972.
- 3. Bosevski M, Stojanka K, Slavco T, Snezana M, Vladimir B, Vera S, et al. Is Fibrinogen And D-Dimers Determination Useful For Prognosis Of Diabetic Polyvascular Disease. Cardiovascular Pathology. 2004; 13(3): 87–8.
- 4. Bąk E, Marcisz C, Kadłubowska M, Michalik A, Krawczyk B, Dobrzyń-Matusiak D, et al. Independent Factors of Changes of Ankle-Brachial Index in Peripheral Arterial Occlusive Disease in Elderly Patients with or without Diabetes. International Journal of Environmental Research and Public Health. 2016; 13(11): 1103.
- 5. Bosevski M, Borozanov V, Peovska I, Georgievska-Ismail L. Endothelial dysfunction correlates with plasma fibrinogen and HDL cholesterol in type 2 diabetic patients with coronary artery disease. Bratislavske Lekarske Listy. 2007; 108(7): 297–300.
- 6. Undas A, Nowakowski T, Cieśla-Dul M, Sadowski J. Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis. 2011; 215(2): 481–6.
- 7. Casini A, Neerman-Arbez M, Ariëns RA, Moerloose PD. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. Journal of Thrombosis and Haemostasis. 2015; 13(6): 909–19.
- 8. Bosevski M, Kostoska S, Tosev S, Borozanov V. Prognostic importance of haemostatic parameters in polyarterial disease. Prilozi. 2005; 26(1): 81–92.16118617